Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.77
Jan. 21, 2025 16:00:00- Change 0.07 (2.5926%)
- Volume 183,514
- Today's Open 2.65
- Previous Close 2.7
- Today's High 3.0299
- Today's Low 2.65
- 52 Week High 4.3
- 52 Week Low 1.57